Chi-Huey Wong

8PUBLICATIONS
4CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical infection agents (incl. prions)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 15, 2025
Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade.

Po-Kai Chuang, Cinya Chung, Kuo-Shiang Liao

|Feb 19, 2025
Cell-based glycoengineering for production of homogeneous and specific glycoform-enriched antibodies with improved effector functions.

Han-Wen Huang, Yi-Fang Zeng, Vidya S Shivatare

|Jan 22, 2024
Increased expression of SSEA-4 on TKI-resistant non-small cell lung cancer with EGFR-T790M mutation.

Nai-Yu Chen, Chih-Wei Lin, Ting-Yen Lai

|Nov 30, 2023
Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein.

Chen-Chun Chen, Han-Wen Huang, Bo-Rui Chen

|Nov 27, 2023
Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).

Cheng-Wei Cheng, Chung-Yi Wu, Szu-Wen Wang

|Apr 18, 2023
Study on antibody Fc-glycosylation for optimal effector functions.

Vidya S Shivatare, Po-Kai Chuang, Tzu-Hao Tseng

Pageof 2